Tim Meyer

Research Group Leader

Tim Meyer leads the Pharmaceutical Biotechnology group at the Institute of Pharmacology and Toxicology of University Medical Center Göttingen and heads the automation department at myriamed GmbH. He is also a Director on the Board of the smartlab society and the SiLA Consortium. His research focuses on engineered heart muscle models, lab automation, and AI-driven biomedical technologies to advance drug screening and reduce animal testing. He earned his PhD in Biomedicine from the University of Barcelona in 2009, followed by postdoctoral positions at the Max Planck Institute for Biophysical Chemistry and the University Medical Center Göttingen. Earlier, he worked at The Scripps Research Institute, the École supérieure de biotechnologie de Strasbourg, Western Sydney University, and the University of Freiburg.